Lantern Pharma 1 article

Lantern Pharma is an AI-enabled oncology company linking molecular-response data, biomarkers and drug-development decisions built around AI-driven oncology. The computational stack also includes RADR drug discovery platform and never-smoker lung cancer therapeutics, tying algorithmic analysis to concrete molecular or immunologic discovery tasks. Taken together, biomarker-guided oncology development and LP-300 small molecule oncology provide additional company-level context without turning a product name, target or platform into a synonym for Lantern Pharma.

Drug Discovery

September 23, 2026, 7:20 AM · 5 mins read

B cell non Hodgkin lymphoma pipeline grows as new trials target aggressive disease

A wave of clinical trials and new drugs is changing the B cell non Hodgkin lymphoma treatment field. More than seventy five companies are now moving over eighty therapies through the pipeline.